EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression

Wanchen Wang, Kohei Kumegawa, Owen S Chapman, Ryo Shiraishi, Zhize Xiao, Konstantin Okonechnikov, Yang Sun, Stefan M Pfister, Weijun Feng, Naofumi Uesaka, Mikio Hoshino, Satoru Takahashi und 4 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.115673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Wanchen Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8052, Japan; Graduate School of Medica…. Hauptthemen laut MEDLINE: Medulloblastoma, Chromatin, DNA-Binding Proteins, Cerebellar Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Nagoya City University, AMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedulloblastomaChromatinDNA-Binding ProteinsCerebellar NeoplasmsDNA HelicasesNeoplasm ProteinsAnimalsHumansMiceDisease ProgressionPatched-1 ReceptorCell DifferentiationHedgehog ProteinsCell ProliferationCell Line, TumorBasic Helix-Loop-Helix Proteins

Stichwörter der Autor:innen

CHD7CP: CancerKMT2Cbrain tumorchromatin modificationsmedulloblastomamouse model

Substanzen

ChromatinDNA-Binding ProteinsDNA HelicasesPatched-1 ReceptorNeoplasm ProteinsHedgehog ProteinsBasic Helix-Loop-Helix ProteinsKMT2C protein, humanChd7 protein, mouse

Autor:innen und Institutionen

  • Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8052, Japan; Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8510, Jap…
  • Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research (JFCR), Tokyo 135-8550, Japan.
  • Department of Medicine, University of California San Diego, La Jolla CA 92037, USA; Department of Neuro-oncology, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University, Aichi 467-8601,…
  • Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8052, Japan.
  • Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Department of Neuro-oncology, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University, Aichi 467-8601, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Nagoya City University
  • AMED
  • National Center of Neurology and Psychiatry
  • Uehara Memorial Foundation
  • Brain Science Foundation
  • Suzuken Memorial Foundation
  • Tokyo Medical and Dental University

Zitieren

APA

Wang, W., Kumegawa, K., Chapman, O. S., Shiraishi, R., Xiao, Z., Okonechnikov, K., Sun, Y., Pfister, S. M., Feng, W., Uesaka, N., Hoshino, M., Takahashi, S., Korshunov, A., Chavez, L., Maruyama, R., & Kawauchi, D. (2025). Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115673

Vancouver

Wang W, Kumegawa K, Chapman OS, Shiraishi R, Xiao Z, Okonechnikov K, et al. Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115673

BibTeX
@article{Wang2025,
  author = {Wang, Wanchen and Kumegawa, Kohei and Chapman, Owen S and Shiraishi, Ryo and Xiao, Zhize and Okonechnikov, Konstantin and Sun, Yang and Pfister, Stefan M and Feng, Weijun and Uesaka, Naofumi and Hoshino, Mikio and Takahashi, Satoru and Korshunov, Andrey and Chavez, Lukas and Maruyama, Reo and Kawauchi, Daisuke},
  title = {Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.115673}
}
Kostenlos starten →